Integra Lifesciences (NASDAQ: IART)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Integra Lifesciences (NASDAQ: IART) through any online brokerage.
The latest price target for Integra Lifesciences (NASDAQ: IART) was reported by Citigroup on Tuesday, May 17, 2022. The analyst firm set a price target for 67.00 expecting IART to rise to within 12 months (a possible 7.49% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Integra Lifesciences (NASDAQ: IART) is $62.33 last updated May 17, 2022, 8:00 PM UTC.
There are no upcoming dividends for Integra Lifesciences.
Integra Lifesciences’s Q2 earnings are confirmed for Wednesday, July 27, 2022.
There is no upcoming split for Integra Lifesciences.
Integra Lifesciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.